[32] reviewed the intricate interplay between chronic inflammation and cancer development and suggested that consequences may be exaggerated tumor progression (via e.g. IL‐6) and development of treatment resistance, whereas acute inflammation may stimulate maturation of dendritic cells and anti‐tumor immune responses. This evidence concerns the gene IL6 and neoplasm.